AREAS OF EXPERTISE
After surgical training in the NHS & Military hospitals on the South Coast of the UK, Mr Philip Charlesworth went to the University of Oxford in 2004 to begin a post-graduate degree in the Molecular Genetics of Urological Malignancies, at the Institute of Molecular Medicine, University of Oxford.
In 2007 Mr Philip Charlesworth initiated his Specialist Surgical training in Urology & Uro-Oncology within the hospitals of Berkshire, Buckinghamshire, Northamptonshire & Oxfordshire. The final years of specialist training were concentrated on robotic surgery, minimally invasive surgery & open surgery for major urological cancers and subsequent surgical reconstruction.
In 2012, Mr Philip Charlesworth was awarded a British Urological Foundation Robotic Preceptorship with Professor Indebir Gill and his robotic surgical team at the University of Southern California Institute of Urology, Los Angeles, California, USA. Professor Inderbir Gill is arguably one of the greatest minimally invasive surgeons in the world. Mr Philip Charlesworth also has experience working with the robotic surgical teams of Guy’s & St Thomas Hospitals, London, Regina Elena Hospital, National Cancer Institute, Rome, Italy, and Harlev University Hospital, Copenhagen.
Mr Philip Charlesworth was appointed as a substantive Consultant Surgeon at the Royal Berkshire Hospital in 2012, and joined the Reading Urology Partnership in 2013. Over this time he has established himself as one of the leaders in pelvic uro-oncology (major prostate & bladder cancer) in the region.
Mr Charlesworth has performed approximately 500 complex robotic major pelvic uro-oncological cancer operations in the past few years, and is ranked as one of the highest volume surgeons according to nationally published statistics.
In April 2014 he became the lead for major pelvic cancer operations for patients in Berkshire and South Oxfordshire, serving a population of 1.1 million people. He now heads the Berkshire Cystectomy Team, and has pioneered a number of exciting developments in bladder cancer surgery, leading to big improvements in patient care, and novel approaches in the subsequent reconstruction to improve functional outcome for his patients following major pelvic cancer surgery.
The biggest development has been the introduction of robotic surgery. Mr Charlesworth now routinely performs these complex operations entirely using the Da Vinci Robotic Surgical System, including bowel reconstruction and new bladder formation, and is one of only a handful of Surgeons in the UK to acheive this. He has been guided by one of the most skillful and experienced robotic Surgeons in the world, Professor Magnus Annerstedt from the famous Institute of Karolinska, Sweden. A centre of international excellence.
Professor Annerstedt has visited Mr Philip Charlesworth on numerous occasions to proctor and oversee the introduction of this new complex surgery. Within the first few years of its introduction Mr Philip Charlesworth has already demonstrated a dramatic reduction in operative blood loss, length of hospital stay, major complication rates and mortality rates.
Furthermore Mr Philip Charlesworth has developed his robotic surgical technique for robotic radical prostatectomy with graded erectile nerve sparing according to the teaching of Professor Vip Patel, Global Robotics Institute, Florida, USA. Professor Vip Patel has now performed approximately 10,000 robotic radical prostatectomies and has established himself as the highest volume robotic surgeon in the world and the pioneer of the most successful nerve sparing and erection preserving surgeon in the world.
In 2017 Mr Charlesworth modified and evolved his technique for Robotic Radical prostatectomy and now routine performs all of his prostate cancer operations using the Retzius Sparing approach. This has demonstrated a dramatic improvement in early recovery of urinary continence. A recent analysis of 150 of these type of operation using this technique show Mr Charlesworth’s patients are recovering their continence within a few days to a few weeks following surgery (80%), and 99% of Mr Charlesworth’s patients have recovered their continence within 6 months. This has seen a dramatic improvement in his patients quality of lives.
Mr Philip Charlesworth has a specialist interest in the diagnosis of prostate cancer, particularly with the novel advancement of specialist MRI scans of the prostate (multiparametric MRIs, mpMRI).
He has worked closely with specialist uro-radiologists across the UK (particularly Berkshire, Oxford & London) to develop optimal ways to visualise and target abnormalities seen on MR imaging.
Traditionally a raised PSA blood test would lead straight to an invasive trans-rectal biopsy. However, Mr Charlesworth uses the emerging technology of mpMRI to exclude Prostate Cancer and avoid many unnecessary and dangerous prostate biopsies.
Furthermore if an abnormality is detected on the mpMRI, Mr Charlesworth has available the latest technology and expertise to target any abnormal areas within the prostate via a transperineal approach. This minimally invasive approach is well tolerated under a local anaesthetic, (although sedation and general anaesthesia is available on request).
Mr Charlesworth can arrange fast access (often same day) specialist prostate mpMRIs in any of his clinics across Reading, Windsor & Harley Street.
Treatments Performed By Mr Philip Charlesworth
Wednesday pm in Windsor
Thursdays in Reading
Friday am in Harley Street
Ad hoc availability also available at request (depending on other clinical committments)
Mondays, Tuesdays, Thursday & some Fridays
(Robotic Surgery performed at The Royal Berkshire Hospital & Princess Grace Hospital, London)
Mr Philip Charlesworth’s clinics offer a comprehensive diagnostic and investigative service for any general urology problems, or specific uro-oncological complaints / concerns.
Please complete the form below or contact his private secretary Maxine to make arrangements for a consultation.
0118 920 7040
Contact your GP and ask for a referral to the Urology Partnership.
All consultations, investigations and treatments are covered by major insurance companies (depending on policy).
Funding your own treatment
Self-funding initial consultation fee is £205. Follow up fees are £165.
Consultation charges are exclusive of any tests and other investigations that the consultant may wish to carry out.